Exane Derivatives’s Innovator US Equity Buffer ETF December BDEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$59.7K Hold
1,962
0.03% 304
2022
Q1
$67.2K Hold
1,962
0.02% 531
2021
Q4
$69.1K Sell
1,962
-2,189
-53% -$74.9K 0.02% 473
2021
Q3
$139K Hold
4,151
0.03% 478
2021
Q2
$138K Hold
4,151
0.03% 498
2021
Q1
$132K Hold
4,151
0.04% 366
2020
Q4
$127K Buy
+4,151
New +$121K 0.04% 363

Other funds holding BDEC

Exane Derivatives's BDEC Position: Q2 2022 in Review

Exane Derivatives held its Innovator US Equity Buffer ETF December (BDEC) position steady in Q2 2022 at 1,962 shares worth $59.7K. The position accounts for 0.03% of the portfolio, ranked #304.

Exane Derivatives first reported a position in BDEC in Q4 2020 and has held it in 7 quarters since. The position peaked at $139K in Q3 2021. 43 funds tracked by Wall St. Rank hold BDEC as of Q2 2022.

  • Exane Derivatives held 1,962 shares of Innovator US Equity Buffer ETF December worth $59.7K as of Q2 2022.
  • Exane Derivatives left its Innovator US Equity Buffer ETF December share count unchanged in Q2 2022.
  • Innovator US Equity Buffer ETF December made up 0.03% of Exane Derivatives's portfolio in Q2 2022, its #304 holding.
  • Exane Derivatives first reported a position in Innovator US Equity Buffer ETF December in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Innovator US Equity Buffer ETF December position peaked at $139K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF December as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.